NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF

Nanobiotix S.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026

$21.08−0.22 (-1.03%)

Close on Oct 19, 2026

Nanobiotix S.A. revenue by segment

Nanobiotix does not break out revenue by segment, region or product in the tagged data of its filings for this period type.